Global analysis of LARP1 translation targets reveals tunable and dynamic features of 5' TOP motifs.
LARP1
TOP mRNA
mTORC1
translation
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
10 03 2020
10 03 2020
Historique:
pubmed:
26
2
2020
medline:
14
7
2020
entrez:
26
2
2020
Statut:
ppublish
Résumé
Terminal oligopyrimidine (TOP) motifs are sequences at the 5' ends of mRNAs that link their translation to the mTOR Complex 1 (mTORC1) nutrient-sensing signaling pathway. They are commonly regarded as discrete elements that reside on ∼100 mRNAs that mostly encode translation factors. However, the full spectrum of TOP sequences and their prevalence throughout the transcriptome remain unclear, primarily because of uncertainty over the mechanism that detects them. Here, we globally analyzed translation targets of La-related protein 1 (LARP1), an RNA-binding protein and mTORC1 effector that has been shown to repress TOP mRNA translation in a few specific cases. We establish that LARP1 is the primary translation regulator of mRNAs with classical TOP motifs genome-wide, and also that these motifs are extreme instances of a broader continuum of regulatory sequences. We identify the features of TOP sequences that determine their potency and quantify these as a metric that accurately predicts mTORC1/LARP1 regulation called a TOPscore. Analysis of TOPscores across the transcriptomes of 16 mammalian tissues defines a constitutive "core" set of TOP mRNAs, but also identifies tissue-specific TOP mRNAs produced via alternative transcription initiation sites. These results establish the central role of LARP1 in TOP mRNA regulation on a transcriptome scale and show how it connects mTORC1 to a tunable and dynamic program of gene expression that is tailored to specific biological contexts.
Identifiants
pubmed: 32094190
pii: 1912864117
doi: 10.1073/pnas.1912864117
pmc: PMC7071917
doi:
Substances chimiques
Autoantigens
0
Pyrimidines
0
RNA, Messenger
0
Ribonucleoproteins
0
Polypyrimidine Tract-Binding Protein
139076-35-0
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5319-5328Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM125955
Pays : United States
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
F1000Res. 2015 Oct 14;4:1070
pubmed: 26674615
Nucleic Acids Res. 2008 Jun;36(11):3707-15
pubmed: 18480124
Genome Biol. 2015 Jan 05;16:22
pubmed: 25723102
Genome Biol. 2014;15(10):476
pubmed: 25273840
Methods. 2017 Aug 15;126:112-129
pubmed: 28579404
Cell Rep. 2017 May 9;19(6):1083-1090
pubmed: 28494858
Bioinformatics. 2009 May 1;25(9):1105-11
pubmed: 19289445
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Genes Dev. 2014 Feb 15;28(4):357-71
pubmed: 24532714
J Biol Chem. 2015 Jun 26;290(26):15996-6020
pubmed: 25940091
Chemistry. 2008;14(30):9135-8
pubmed: 18767078
PLoS One. 2014 Oct 22;9(10):e109410
pubmed: 25338081
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nature. 2012 May 02;485(7396):109-13
pubmed: 22552098
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Nucleic Acids Res. 2018 Feb 16;46(3):1457-1469
pubmed: 29244122
J Mol Biol. 2002 Jun 7;319(3):615-35
pubmed: 12054859
RNA. 2009 May;15(5):750-64
pubmed: 19299548
Nature. 2012 Feb 22;485(7396):55-61
pubmed: 22367541
Elife. 2017 Feb 08;6:
pubmed: 28177284
Mol Cell. 2017 Jul 6;67(1):55-70.e4
pubmed: 28673543
Cell. 2009 Feb 20;136(4):731-45
pubmed: 19239892
Elife. 2017 Apr 07;6:
pubmed: 28379136
Nucleic Acids Res. 2010 Jan;38(Database issue):D98-104
pubmed: 19910371
Biochim Biophys Acta. 2015 Jul;1849(7):801-11
pubmed: 25234618
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Mol Cell Biol. 1994 Jun;14(6):3822-33
pubmed: 8196625
J Biol Chem. 2009 Mar 20;284(12):8023-32
pubmed: 19150980
Org Lett. 2010 May 21;12(10):2190-3
pubmed: 20420425